Generating a robust prediction model for stage I lung adenocarcinoma recurrence after surgical resection

Keyphrases

• 5-year Survival 33%
• Adjuvant Therapy 66%
• Advanced Lung Adenocarcinoma 100%
• Clinical Outcomes 33%
• Clustering Methods 33%
• Curative Resection 33%
• Disease-free Survival 33%
• Effective Model 33%
• Formalin-fixed Paraffin-embedded Tissue 33%
• Gene Expression Profile 33%
• General Hospital 33%
• Hazard Ratio 33%
• High Risk 100%
• Low Risk 66%
• Low-risk Group 33%
• Low-risk Patients 33%
• Lung Adenocarcinoma 66%
• Lung Cancer Risk 33%
• Paraffin-embedded Tissue 33%
• Patient Benefit 33%
• Performance Prediction 33%
• Prediction Model 100%
• Published Results 33%
• Resection 33%
• Robust Prediction Model 100%
• Robust Training 33%
• Stage IB 33%
• Supervised Clustering 33%
• Surgical Resection 100%
• Taipei 33%
• Test Validity 33%
• Tissue Microarray 33%
• Training Process 33%
• Training Test 33%

Medicine and Dentistry

• Adjuvant Therapy 50%
• Cancer Mortality 25%
• Disease Free Survival 50%
• Formaldehyde 25%
• Gene Expression 25%
• Hazard Ratio 25%
• Low Risk Population 25%
• Lung Adenocarcinoma 100%
• Lung Cancer 25%
• Recurrent Disease 100%
• Surgery 100%

Biochemistry, Genetics and Molecular Biology

• Cancer Mortality 50%
• Disease Free Survival 100%
• Gene Expression 50%
• Low Risk Population 50%
• Microarrays 50%